The FDA has "repeatedly stated that effectiveness against transmission remains unproven," the trio write, noting that the agency’s website maintains: "the scientific community does not yet know if Comirnaty will reduce such transmission."
The study discovered that "the overall risk of retinal vascular occlusion in the vaccinated cohort was 2.19 times higher than that in the unvaccinated cohort at 2 years (95% Cl 2.00–2.39)."
The research was conducted in three Finnish cities with similar baseline COVID-19 incidences between August and September 2021: Helsinki, Turku, and Tampere.
"As Attorney General, I will protect children and enforce the laws as written, which includes upholding state law on experimental gender transition interventions," said AG Bailey.
COVID-19 vaccines pose risks of thrombosis and hemolysis for people with blood disorders, while certain adverse effects are linked to vaccines, according to a new journal article in Frontiers that calls for extra caution and future research.